Diaphragmatic Work During HFNC and CPAP Support

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-11-27

Study Completion Date

2025-11-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this randomised controlled, cross-over clinical trial is to compare High Flow Nasal Cannulas (HFNC) and Continuous Positive Airways Pressure (CPAP) in neonates over 34 weeks' amenorrhoea (SA) up to children weighing less than 20 kg with respiratory failure.

The main question it aims to answer is the non-inferiority of high flows of high-flow nasal cannula compared with CPAP by analysis of diaphragmatic contraction (EAdi (Electrical activity of diaphragm)).

Participants with respiratory failure and need of non invasive ventilation and nasogastric tube will receive 4 different increasing flows of HFNC and Positive End-Expiratory Pressure of 7 cmH2O with CPAP during 30 minutes for each flow rate and CPAP. The electrical activity of diaphragm and clinical data of the patient upon each flow and support will be collected. According to the cross-over procedure, the patients will change groups (increasing flows of HFNC or CPAP) in order to perform the remaining analysis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of the Effects of CPAP and HHHFNC on Diaphragmatic Dimensions in Preterm Infants

NCT02421328

Respirtory Distress

COMPLETED NA

Humidified High Flow Nasal Cannula Versus Nasal Intermittent Positive Ventilation in Neonates

NCT02499744

Respiratory Insufficiency

UNKNOWN PHASE1

Patient Comfort During High Flow Nasal Cannula Versus Nasal Continuous Airway Pressure (CPAP)

NCT01526226

Respiratory Distress Syndrome, Newborn Medical Device Discomfort

COMPLETED NA

Interest of High Flow Nasal Cannula (HFNC) Versus Non Invasive Ventilation During the Initial Management of Severe Bronchiolitis in Infants

NCT02457013

Bronchiolitis

UNKNOWN NA

Effect of Cannula Size on Oxygen Saturation During Nasal High Flow Therapy in Newborns

NCT04459429

RDS - Infants TTN

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

With this research protocol, the investigators aim to demonstrate the non-inferiority of high flows of HFNC compared with CPAP on work of breathing (based on the intensity of contraction of diaphragmatic fibres and clinical aspects) in paediatric and neonatal patients. The investigators will also study the clinical tolerance and safety of these practices.

Objectives :

Main objective: To demonstrate the non-inferiority of high-flow nasal cannula flow rates compared with CPAP by analysis of diaphragmatic contraction (EAdi (Electrical activity of diaphragm)) in neonates over 34 weeks' amenorrhoea (SA) up to children weighing less than 20 kg in respiratory failure.

Secondary objectives:

* To compare different flows of HFNC (2 L/kg/min, 3 L/kg/min, 4 L/kg/min, 5 L/kg/min) with each other by analysing diaphragmatic contraction.
* Compare the clinical effectiveness of different flow rates of HFNC with CPAP in young children in respiratory distress.
* To compare the tolerability of different flow rates of HFNC with CPAP in the population of young children suffering from respiratory distress.
* To compare the incidence of minor (digestive discomfort, digestive bloating, non-damaging skin lesions) and major (thoracic barotrauma, damaging skin lesions) side effects of different flow rates of HFNC with CPAP in young children in respiratory distress.
* To describe the choice of support and settings (flow rates or PEEP levels) made by the practitioners in charge of the child after the study period.
* To describe the epidemiological data from the paediatric intensive care and monitoring units and the neonatal intensive care unit.

Type of study: Randomised controlled, cross-over, single-centre, non-inferiority trial of a medical device.

Number of centres: 1

Study design:

Upon admission to the department, if the eligibility criteria are met and the parents agree to the research , a wash-out period will be performed under low-flow oxygen therapy at 1 L/min to achieve SpO2 ≥ 94% for 15 minutes.

The included patients will then be randomized into two separate groups: a CPAP group with PEEP at 7 cmH2O for 30 minutes and an HFNC group with increasing flow rates for up to 2 hours.

The patients included will be their own controls and at the end of the first analysis, according to the cross-over procedure, the patients will change groups in order to perform the remaining analysis.

A recourse procedure has been foreseen in case of failure of ventilatory support.

Medical devices :

Concerning HFNC ventilation:

The nasal cannulas used are Optiflow® cannulas (Fisher and Paykel Laboratory) which will be adapted to the size of each patient's nostrils. The following sizes are available:

* NICU patient: Optiflow Junior 2®.
* PICU patient: Optiflow Junior 2®, Optiflow +®.

Concerning CPAP ventilation:

* For the neonatal population:

* Medin Sindi® CPAP masks, caps and ties
* Medin Miniflow® CPAP generators
* For the paediatric population :

* Medin Sindi® CPAP masks, caps and ties
* Fisher and Paykel Healthcare CPAP masks, cannulas and caps
* Miniflow® CPAP generators from Medin
* Fisher and Paykel Healthcare CPAP generators

Expected benefits :

If it is shown that a reduction in the work of breathing is observed (EAdi and usual clinical signs) when HFNC flow rates are gradually increased, and that this increase to flow rates of 3 to 5 L/kg/min is well tolerated and does not increase the risk of barotrauma, HFNC ventilation at flow rates greater than 2 L/kg/min could be more widely proposed and accepted in the various units using it, as it is unanimously accepted in terms of tolerance and comfort for the patient compared with CPAP.

Recruitment procedures The patients eligible for this study will be those admitted to the neonatal and paediatric intensive care unit of the Clermont-Ferrand University Hospital by a doctor on the unit and who meet the various inclusion criteria for the study.

An information note has been drawn up and will be presented and explained to the child's legal representative(s) by an investigating doctor during their usual care, as well as to the child if his or her level of understanding is adequate, within 2 hours of admission to the department. The parents and the child will have a maximum of 1 hour to reflect (and a maximum of 3 hours from admission to the ward) between the time they are given the information and the time they sign the consent form.

Legal representative(s) will then be asked to sign the written consent. The child's inclusion in the DiaworkHFNC protocol will be recorded in the child's computerised medical record (ICCA software).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Insufficiency in Children Newborn Rds Nasal Cannula CPAP Ventilation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

The included patients will then be randomized into two separate groups: a CPAP group with PEEP at 7 cmH2O for 30 minutes and an HFNC group with increasing flow rates from 2L/kg/min to 5 L/kg/min with 30 minutes of study for each flow. After a wash-out period of 15 minutes, according to the cross-over procedure, the patients will change groups in order to perform the remaining analysis.

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CPAP-first group

After a wash out of 15 minutes with conventional oxygen therapy, CPAP with a Positive End -Expiratory Pressure of 7 cmH2O will be introduced, with an inspiratory oxygen fraction required for an oxygen saturation of 94%, during 30 minutes. The collection of EAdi min/max will be done every minutes over 30min as well as the collection of HR, Respiratory rate (RR), SpO2, while TCPCO2, distress respiratory score and pain score will be taken at M0 and M30.

Group Type ACTIVE_COMPARATOR

Non invasive ventilation

Intervention Type DEVICE

CPAP and increasing flows of HFNC will be compared during a 30-minutes period each

HFNC-first group

After a wash out of 15 minutes with conventional oxygenotherapy, increasing flow rates for up to 2 hours according to the following augmentation:

* Initiation at a flow rate of 2 L/kg/min with FiO2 required to achieve SpO2≥94% (increase FiO2 if reliable SpO2 signal \<94% for 1 minute) for 30min.
* Increase to 3 L/kg/min after the first 30min of ventilation and repeat the previously described experimental scheme.
* Further increase to 4 L/kg/min after 30min of ventilation and repetition of the experimental scheme (if weight \< 16 kg).
* Last increase to 5 L/kg/min after 30 min of ventilation and repetition of the experimental scheme (if weight \< 13 kg).

The collection of EAdi min/max will be done every minutes over 30min as well as the collection of HR, RR, SpO2, while TCPCO2, distress respiratory score and pain score will be taken at M0 and M30.

Group Type ACTIVE_COMPARATOR

Non invasive ventilation

Intervention Type DEVICE

CPAP and increasing flows of HFNC will be compared during a 30-minutes period each

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non invasive ventilation

CPAP and increasing flows of HFNC will be compared during a 30-minutes period each

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Newborns over 34 SA and paediatric patients weighing less than 20 kg.
* Need for ventilatory support by HFNC or CPAP for respiratory failure
* Need for enteral feeding via nasogastric tube
* Hospitalized in PICU or NICU at Clermont-Ferrand University Hospital,
* Covered by Social Security.
* Whose parents or guardians are able to provide informed consent to participate in the research.

Exclusion Criteria

* Respiratory failure requiring immediate intubation.
* Use of HFNC or CPAP as a relay to extubation.
* Acquired or congenital abnormality of the gastrointestinal tract.
* Diaphragmatic paralysis and/or neuromuscular pathology
* Failure of central ventilatory control (e.g. intra-ventricular haemorrhage, anoxic-ischaemic encephalopathy, massive vascular accident, intracranial process, cerebral edema and/or intracranial hypertension).
* Contraindications listed in the CPAP and HFNC user manuals: absence of spontaneous ventilation, choanal atresia, diaphragmatic hernia, tracheo-oesophageal fistula, nasal trauma, severe deformity likely to be aggravated by the nasal mask or nasal cannula, pneumothorax, pneumencephaly, Cerebrospinal Fluid leak, hypotension.
* Refusal by parents or guardians.

Minimum Eligible Age

34 Weeks

Maximum Eligible Age

6 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No